Studie AGO-OVAR-20 (PAOLA-1)

AGO-OVAR-20 (PAOLA-1)

Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with
Advanced FIGO Stage IIIB – IV High Grade Serous or Endometrioid Ovarian, Fallopian
Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining
Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy
and in Maintenance

Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany

III

Rekrutierung beendet

Unbekannt / Unbekannt

Chemo,Zielgerichtet